Literature DB >> 16603930

Brain amyloid accumulates in aged rats with kaolin-induced hydrocephalus.

Petra M Klinge1, Amir Samii, Sabine Niescken, Thomas Brinker, Gerald D Silverberg.   

Abstract

Amyloid beta-peptide (Abeta) accumulation in aged Sprague-Dawley rats (12 months) with kaolin-induced hydrocephalus was investigated by Abeta(1-40) and Abeta(1-42) immunohistochemistry at 2, 6 and 10 weeks after induction. The low-density lipoprotein receptor-related protein-1 transporting Abeta across the blood-brain barrier was assayed. Age-matched controls showed some positive Abeta staining, mainly in the choroid plexus. At 2 weeks after induction, Abeta staining of the arachnoid and subependymal layer was observed. At 6 weeks, larger Abeta accumulations were prominent at the endothelial and perivascular sites. Intraparenchymal Abeta positively stained accumulations occurred at 10 weeks. Microvessel lipoprotein receptor-related protein-1 staining was progressively reduced from 2 to 10 weeks. The pattern of Abeta deposition and lipoprotein receptor-related protein-1 loss suggests reduced Abeta clearance in chronic hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603930     DOI: 10.1097/00001756-200604240-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Brian R Ott; Ronald A Cohen; Assawin Gongvatana; Ozioma C Okonkwo; Conrad E Johanson; Edward G Stopa; John E Donahue; Gerald D Silverberg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 3.  Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.

Authors:  Berislav V Zlokovic; Rashid Deane; Abhay P Sagare; Robert D Bell; Ethan A Winkler
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

Review 4.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Environmental factors in the development and progression of late-onset Alzheimer's disease.

Authors:  Moses N Wainaina; Zhichun Chen; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2014-03-24       Impact factor: 5.203

6.  Reduced CSF turnover and decreased ventricular Aβ42 levels are related.

Authors:  Jean-Marie Serot; Johann Peltier; Antony Fichten; Nelly Ledeme; Anne-Marie Bourgeois; Pierre Jouanny; Patrick Toussaint; Daniel Legars; Olivier Godefroy; Jean-Claude Mazière
Journal:  BMC Neurosci       Date:  2011-05-13       Impact factor: 3.288

7.  Magnetic resonance imaging indicators of blood-brain barrier and brain water changes in young rats with kaolin-induced hydrocephalus.

Authors:  Marc R Del Bigio; Ili Slobodian; Angela E Schellenberg; Richard J Buist; Tanya L Kemp-Buors
Journal:  Fluids Barriers CNS       Date:  2011-08-11

8.  Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease.

Authors:  Gerald Silverberg; Martha Mayo; Thomas Saul; Jere Fellmann; Dawn McGuire
Journal:  Cerebrospinal Fluid Res       Date:  2006-05-31

9.  Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus.

Authors:  Kelley E Deren; Jennifer Forsyth; Osama Abdullah; Edward W Hsu; Petra M Klinge; Gerald D Silverberg; Conrad E Johanson; James P McAllister
Journal:  Cerebrospinal Fluid Res       Date:  2009-05-26

10.  Is it all about Contact? Neurodegeneration as a "Protein Freeze Tag Game" Inside the Central Nervous System.

Authors:  Tobias A Mattei
Journal:  Front Neurol       Date:  2013-06-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.